Anebulo Pharmaceuticals Inc. Gains 42.69%
Tue, Oct 17, 2023 at 07:17 PM
Anebulo Pharmaceuticals Inc. (ANEB:NASDAQ) jumped higher at $2.44, representing a gain of 42.7%. The stock appeared on our News Catalysts scanner on Fri, Oct 06, 2023 at 06:49 PM in the 'INVESTOR UPDATE' category. From Tue, Oct 03, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days
About Anebulo Pharmaceuticals Inc. (ANEB:NASDAQ)
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction.
Top 10 Gainers:
- SciSparc Ltd. (SPRC:NASDAQ), 122.97%
- Nkarta Inc. (NKTX:NASDAQ), 112.16%
- Viveve Medical, Inc. (VIVE:NASDAQ), 78.95%
- Assembly Biosciences, Inc. (ASMB:NASDAQ), 72.18%
- Olink Holding AB (publ) (OLK:NASDAQ), 66.02%
- Aravive, Inc. (ARAV:NASDAQ), 61.9%
- Anebulo Pharmaceuticals Inc. (ANEB:NASDAQ), 42.69%
- RedHill Biopharma Ltd. (RDHL:NASDAQ), 34.1%
- Gamer Pakistan Inc. (GPAK:NASDAQ), 32%
- Ramaco Resources, Inc. (METC:NASDAQ), 28.82%